Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle N Ferreira

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Advanced Drug Delivery Reviews|September 4, 2021
Guiding immunotherapy combinations: Who gets what?Michelle N Ferreira, Jennifer H Choe
International Journal of Women'S Dermatology|April 26, 2021
Dermatologic toxicities associated with radiation therapy in women with breast cancerJulie Y Ramseier, Michelle N Ferreira, Jonathan S Leventhal
International Journal of Women'S Dermatology|January 8, 2020
Dermatologic conditions in women receiving systemic cancer therapyMichelle N Ferreira, Julie Y Ramseier, Jonathan S Leventhal
Journal of Palliative Medicine|June 13, 2022
Top Ten Tips Palliative Care Clinicians Should Know About Managing Immune-Mediated Endocrine Toxicities in CancerMichelle N Ferreira, Meghana Rao, Arif H Kamal, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Advanced Drug Delivery Reviews|September 4, 2021
Guiding immunotherapy combinations: Who gets what?Michelle N Ferreira, Jennifer H Choe
International Journal of Women'S Dermatology|April 26, 2021
Dermatologic toxicities associated with radiation therapy in women with breast cancerJulie Y Ramseier, Michelle N Ferreira, Jonathan S Leventhal
International Journal of Women'S Dermatology|January 8, 2020
Dermatologic conditions in women receiving systemic cancer therapyMichelle N Ferreira, Julie Y Ramseier, Jonathan S Leventhal
Journal of Palliative Medicine|June 13, 2022
Top Ten Tips Palliative Care Clinicians Should Know About Managing Immune-Mediated Endocrine Toxicities in CancerMichelle N Ferreira, Meghana Rao, Arif H Kamal, et al.
Pageof 1